Unleash your team's full potential with CEimpact's comprehensive Business Solutions
Empower Your Team Today
Login

COVID-19 Update: Convalescent Plasma and Tocilizumab | GameChangers

ceimpact September 2, 2020 Comments (0)

The COVID-19 pandemic continues to rage on worldwide. Data surrounding the treatment of patients with COVID-19 respiratory failure is moving at lightning pace, so for this week’s episode we will discuss the latest (as of 8/13/20) information surrounding two modalities for COVID-19 treatment: convalescent plasma and tocilizumab. 

This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!

See omnystudio.com/policies/listener for privacy information.

Tags:
Share:

ceimpact

CEImpact: Empowering Pharmacists for Lasting Impact

At CECImpact, we are passionate about nurturing and empowering pharmacists and pharmacy teams. Our goal is to ignite their potential and elevate the health and wellness of patients through transformative education. With innovative solutions and inspiration, we develop skilled professionals who make a lasting impact on patient care.

Join us in reshaping the future of pharmacy education and contributing to the well-being of countless individuals. Let's embark on this transformative journey together

COVID-19 September 2, 2020
Providing High Quality Care in Rheumatoid Arthritis September 2, 2020

Leave a Comment

Categories

0